A case report highlights the use of combination therapy with mycophenolate mofetil, nintedanib, and tocilizumab in a patient with progressive systemic sclerosis-associated interstitial lung disease. This study contributes to the understanding of treatment options for this complex condition.
combination therapy with mycophenolate mofetil nintedanib and tocilizumab in a patient with progressive systemic sclerosis associated interstitial lung disease a case report and a literature review
Original title: “Combination therapy with mycophenolate mofetil, nintedanib, and tocilizumab in a patient with progressive systemic sclerosis-associated interstitial lung disease : A case report and a literature review.”